OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
Claire Sun, Paul Daniel, Gabrielle Bradshaw, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 660-677.e7
Open Access | Times Cited: 34
Claire Sun, Paul Daniel, Gabrielle Bradshaw, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 660-677.e7
Open Access | Times Cited: 34
Showing 1-25 of 34 citing articles:
Applications of artificial intelligence in clinical laboratory genomics
Swaroop Aradhya, Flavia M. Facio, Hillery C. Metz, et al.
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2023) Vol. 193, Iss. 3
Open Access | Times Cited: 28
Swaroop Aradhya, Flavia M. Facio, Hillery C. Metz, et al.
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2023) Vol. 193, Iss. 3
Open Access | Times Cited: 28
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma
Ryan J. Duchatel, Evangeline R. Jackson, Sarah Parackal, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 6
Open Access | Times Cited: 13
Ryan J. Duchatel, Evangeline R. Jackson, Sarah Parackal, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 6
Open Access | Times Cited: 13
Paediatric Strategy Forum for Medicinal Product Development in Diffuse Midline Gliomas in Children and Adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration
Andrew D.J. Pearson, Sabine Mueller, Mariella G. Filbin, et al.
European Journal of Cancer (2025) Vol. 217, pp. 115230-115230
Open Access | Times Cited: 1
Andrew D.J. Pearson, Sabine Mueller, Mariella G. Filbin, et al.
European Journal of Cancer (2025) Vol. 217, pp. 115230-115230
Open Access | Times Cited: 1
CAR T cell therapies for diffuse midline glioma
Bryce C. Thomas, Dilana E. Staudt, Alicia M. Douglas, et al.
Trends in cancer (2023) Vol. 9, Iss. 10, pp. 791-804
Open Access | Times Cited: 19
Bryce C. Thomas, Dilana E. Staudt, Alicia M. Douglas, et al.
Trends in cancer (2023) Vol. 9, Iss. 10, pp. 791-804
Open Access | Times Cited: 19
GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant
Ilon Liu, Gustavo Alencastro Veiga Cruzeiro, Lynn Bjerke, et al.
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1528-1548.e17
Open Access | Times Cited: 8
Ilon Liu, Gustavo Alencastro Veiga Cruzeiro, Lynn Bjerke, et al.
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1528-1548.e17
Open Access | Times Cited: 8
The present and future of the Cancer Dependency Map
Rand Arafeh, Tsukasa Shibue, Joshua M. Dempster, et al.
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 8
Rand Arafeh, Tsukasa Shibue, Joshua M. Dempster, et al.
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 8
Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies
Luke J. Weisbrod, Thiraviyam Anand, Raghupathy Vengoji, et al.
Cancer Letters (2024) Vol. 590, pp. 216876-216876
Closed Access | Times Cited: 7
Luke J. Weisbrod, Thiraviyam Anand, Raghupathy Vengoji, et al.
Cancer Letters (2024) Vol. 590, pp. 216876-216876
Closed Access | Times Cited: 7
Poly-pharmacology of existing drugs: How to crack the code?
Baptiste Mouysset, Marion Le Grand, Luc Camoin, et al.
Cancer Letters (2024) Vol. 588, pp. 216800-216800
Open Access | Times Cited: 5
Baptiste Mouysset, Marion Le Grand, Luc Camoin, et al.
Cancer Letters (2024) Vol. 588, pp. 216800-216800
Open Access | Times Cited: 5
Developmental origins shape the paediatric cancer genome
Xiaolong Chen, Wentao Yang, Charles W.M. Roberts, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 6, pp. 382-398
Closed Access | Times Cited: 4
Xiaolong Chen, Wentao Yang, Charles W.M. Roberts, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 6, pp. 382-398
Closed Access | Times Cited: 4
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer
Andrew D.J. Pearson, Steven G. DuBois, Margaret E. Macy, et al.
European Journal of Cancer (2024) Vol. 207, pp. 114145-114145
Closed Access | Times Cited: 4
Andrew D.J. Pearson, Steven G. DuBois, Margaret E. Macy, et al.
European Journal of Cancer (2024) Vol. 207, pp. 114145-114145
Closed Access | Times Cited: 4
The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Jie Fang, Shivendra V. Singh, Brennan Wells, et al.
(2025)
Open Access
Jie Fang, Shivendra V. Singh, Brennan Wells, et al.
(2025)
Open Access
The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Jie Fang, Shivendra V. Singh, Brennan Wells, et al.
(2025)
Open Access
Jie Fang, Shivendra V. Singh, Brennan Wells, et al.
(2025)
Open Access
The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Jun J. Yang, Jie Fang, Shivendra V. Singh, et al.
Research Square (Research Square) (2025)
Open Access
Jun J. Yang, Jie Fang, Shivendra V. Singh, et al.
Research Square (Research Square) (2025)
Open Access
Global, regional, and national childhood brain and central nervous system cancer burden: An analysis based on the Global Burden of Disease Study
Zhenjin Su, Jie Lu, Yuheng Shi, et al.
Research Square (Research Square) (2025)
Closed Access
Zhenjin Su, Jie Lu, Yuheng Shi, et al.
Research Square (Research Square) (2025)
Closed Access
Multidimensional, integrative profiling identifies BCL2L1 methylation as a predictor of MCL1 dependency in pediatric malignancies
Shazia Adjumain, Paul Daniel, Claire Sun, et al.
JCI Insight (2025) Vol. 10, Iss. 2
Open Access
Shazia Adjumain, Paul Daniel, Claire Sun, et al.
JCI Insight (2025) Vol. 10, Iss. 2
Open Access
Personalized prediction of anticancer potential of non-oncology drugs through learning from genome derived molecular pathways
Xiaobao Dong, Huanhuan Liu, Ting Tong, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Xiaobao Dong, Huanhuan Liu, Ting Tong, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas
Konstantinos Vazaios, Patricia Hernández López, Tineke Aarts‐Riemens, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2167-2167
Open Access
Konstantinos Vazaios, Patricia Hernández López, Tineke Aarts‐Riemens, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2167-2167
Open Access
The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Jun J. Yang, Jie Fang, Shivendra V. Singh, et al.
(2025)
Open Access
Jun J. Yang, Jie Fang, Shivendra V. Singh, et al.
(2025)
Open Access
Targeting the HLA-E–NKG2A axis in combination with MS-275 enhances NK cell-based immunotherapy against DMG
Yuxuan Deng, Jinqiu Liu, Zhuonan Pu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Yuxuan Deng, Jinqiu Liu, Zhuonan Pu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Ubiquitination in lipid metabolism reprogramming: implications for pediatric solid tumors
Weixin Zhang, Yile Xu, Yapeng Fang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Weixin Zhang, Yile Xu, Yapeng Fang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles
Konstantinos Vazaios, Εftychia Stavrakaki, Lisette B. Vogelezang, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200804-200804
Open Access | Times Cited: 3
Konstantinos Vazaios, Εftychia Stavrakaki, Lisette B. Vogelezang, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200804-200804
Open Access | Times Cited: 3
Generation of a biliary tract cancer cell line atlas reveals molecular subtypes and therapeutic targets
Vindhya Vijay, Negin Karisani, Lei Shi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 3
Vindhya Vijay, Negin Karisani, Lei Shi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 3
The Landscape of Pediatric High-Grade Gliomas: The Virtues and Pitfalls of Pre-Clinical Models
Liam Furst, Enola M. Roussel, Ryan F. Leung, et al.
Biology (2024) Vol. 13, Iss. 6, pp. 424-424
Open Access | Times Cited: 2
Liam Furst, Enola M. Roussel, Ryan F. Leung, et al.
Biology (2024) Vol. 13, Iss. 6, pp. 424-424
Open Access | Times Cited: 2
Characterization of aberrant splicing in pediatric central nervous system tumors revealsCLK1as a candidate oncogenic dependency
Ammar S. Naqvi, Ryan J. Corbett, Priyanka Seghal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Ammar S. Naqvi, Ryan J. Corbett, Priyanka Seghal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
A protocol to establish cell line models from rare pediatric solid tumors
Nicole J. Chew, Dilru Habarakada, Ron Firestein, et al.
STAR Protocols (2023) Vol. 4, Iss. 3, pp. 102537-102537
Open Access | Times Cited: 4
Nicole J. Chew, Dilru Habarakada, Ron Firestein, et al.
STAR Protocols (2023) Vol. 4, Iss. 3, pp. 102537-102537
Open Access | Times Cited: 4
